Clinical Trials Browser

Recruiting × Carcinoma, Hepatocellular × sintilimab × Clear all

NCT07490262 2026-04-16

A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.

Phase 2/3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT07521852 2026-04-13

A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT07331883 2026-03-27

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06530251 2026-03-04

A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)

Phase 1/2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT07157969 2025-12-01

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT07186621 2025-09-22

Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06031285 2025-07-23

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06860490 2025-03-26

HAIC Combined with Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05713994 2025-03-25

CCGLC-001

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06333561 2025-02-06

HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma

Gastrointestinal

Carcinoma, Hepatocellular

NCT06558227 2024-12-16

Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06313190 2024-11-18

HSBRT2402

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06664996 2024-10-30

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06070636 2024-08-09

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT06090656 2024-07-03

BEST

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05717738 2024-06-13

CCGLC-008

Gastrointestinal

Carcinoma, Hepatocellular

NCT05992584 2023-09-14

Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05608200 2023-05-31

Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular